Clarivate Reports Q4 2025 Earnings and Strategic Outlook
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 6 days ago
0mins
Should l Buy CLVT?
Source: seekingalpha
- Strong Financial Performance: Clarivate achieved $2.455 billion in revenue for FY 2025, with Q4 revenue at $617 million and a net income of $3 million, demonstrating robust financial growth, particularly with free cash flow reaching $365 million, indicating ongoing improvements in cash management and profitability.
- Strategic Restructuring Plan: The company announced plans to sell its Life Sciences & Health business, which is expected to accelerate shareholder value creation, with management emphasizing that this move will allow for greater focus on operational execution in the Academia & Government and Intellectual Property segments, thereby enhancing market competitiveness.
- AI-Driven Growth: Clarivate's AI products in Life Sciences & Health have attracted 11,000 global active users, with management noting that 97% of revenue comes from proprietary assets, showcasing the company's strong advantage in AI technology application, which helps to enhance customer retention and market share.
- Optimistic Future Outlook: Management anticipates a 10% growth in free cash flow for 2026 and plans to achieve 2% to 3% organic contract value growth, reflecting confidence in future growth while also indicating ongoing investments in innovation and product development.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CLVT?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CLVT
Wall Street analysts forecast CLVT stock price to rise
5 Analyst Rating
0 Buy
3 Hold
2 Sell
Moderate Sell
Current: 2.300
Low
3.00
Averages
3.90
High
5.00
Current: 2.300
Low
3.00
Averages
3.90
High
5.00
About CLVT
Clarivate Plc is a global provider of transformative intelligence. The Company offers enriched data, insights and analytics, workflow solutions and expert services in the areas of Academia & Government (A&G), Intellectual Property (IP) and Life Sciences & Healthcare (LS&H). Within the A&G segment, the Company offers solutions across various areas, which include scientific and academic research, information solutions and library software. Its ProQuest One solutions provide access to multidisciplinary curated content across a variety of formats, including data bases, dissertations, news, primary sources, books, and video. Within the IP segment, the Company provides IP data, software, and expertise to other companies to manage and protect critical IP assets. This segment's service offerings include IP management software, Patent services and Brand IP solutions, among others. Within the LS&H segment, the Company offers solutions across research and development, commercial and Medtech.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Clarivate Reports Strong Q4 Results and Optimistic 2026 Guidance
- Financial Performance Exceeds Expectations: Clarivate reported Q4 2025 revenue of $617 million, surpassing analysts' estimates of $604.8 million, indicating strong performance in the research database and brand management sectors, which boosts market confidence.
- Improved Profitability: The company posted adjusted earnings per share (EPS) of $0.20, exceeding the anticipated $0.16, reflecting ongoing improvements in profitability that may attract more investor interest.
- Free Cash Flow Growth: Clarivate reported Q4 2025 free cash flow of $89.2 million, a 50.9% year-over-year increase, despite a 6.9% decline in sales, demonstrating enhanced operational efficiency.
- Optimistic 2026 Guidance: Management projects adjusted EPS for 2026 between $0.70 and $0.80, with the midpoint indicating an 8.7% year-over-year increase, while free cash flow is expected to range from $365 million to $435 million, highlighting the company's growth potential.
See More
Clarivate Shares Surge 31.4% Following Strong Q4 Earnings Report
- Earnings Beat: Clarivate reported non-GAAP earnings of $0.20 per share and sales of $617 million for Q4, surpassing analyst expectations of $0.16 and $604.8 million, indicating strong market performance despite a year-over-year revenue decline of approximately 7%.
- Stable Subscription Revenue: Subscription revenue decreased slightly from $407 million to $405.8 million, yet organic growth showed a 1% increase, reflecting the company's resilience in maintaining its customer base and revenue streams, which boosts market confidence.
- Optimistic Outlook: Clarivate is targeting a 10% growth in free cash flow this year, with annual contract value expected to grow between 2% and 3%, and recurring organic revenue projected to rise by 1% to 2%, providing investors with confidence that contributed to the stock surge.
- Strategic Restructuring: The company is in active discussions to sell its life sciences and healthcare business to reduce debt and improve its balance sheet, while planning to expand in academia and government and intellectual property sectors, which could lay a foundation for future growth.
See More
Clarivate Exceeds Q4 Sales and Earnings Expectations
- Earnings Beat: Clarivate reported non-GAAP earnings of $0.20 per share and sales of $617 million in Q4, surpassing analyst expectations of $0.16 and $604.8 million, indicating strong market performance.
- Optimistic Sales Outlook: Although revenue declined approximately 7% year-over-year, the drop was less severe than anticipated, with subscription revenue slightly down to $405.8 million but showing a 1% organic growth, reflecting stability in core operations.
- Cash Flow and Contract Value Targets: The company is targeting a 10% growth in free cash flow this year, forecasting a 2% to 3% increase in annual contract value, while organic revenue is projected to rise between 1% and 2%, which will enhance its financial health.
- Strategic Business Sale: Clarivate is in active discussions to sell its life sciences and healthcare business, intending to use the proceeds to reduce debt, improve its balance sheet, and expand in academia and government as well as intellectual property sectors, demonstrating a strategic focus on future growth.
See More
Clarivate Reports Q4 2025 Earnings and Strategic Outlook
- Strong Financial Performance: Clarivate achieved $2.455 billion in revenue for FY 2025, with Q4 revenue at $617 million and a net income of $3 million, demonstrating robust financial growth, particularly with free cash flow reaching $365 million, indicating ongoing improvements in cash management and profitability.
- Strategic Restructuring Plan: The company announced plans to sell its Life Sciences & Health business, which is expected to accelerate shareholder value creation, with management emphasizing that this move will allow for greater focus on operational execution in the Academia & Government and Intellectual Property segments, thereby enhancing market competitiveness.
- AI-Driven Growth: Clarivate's AI products in Life Sciences & Health have attracted 11,000 global active users, with management noting that 97% of revenue comes from proprietary assets, showcasing the company's strong advantage in AI technology application, which helps to enhance customer retention and market share.
- Optimistic Future Outlook: Management anticipates a 10% growth in free cash flow for 2026 and plans to achieve 2% to 3% organic contract value growth, reflecting confidence in future growth while also indicating ongoing investments in innovation and product development.
See More
Defense Contracts Enhance Visibility for NAPC Defense
- Defense Contract Update: NAPC Defense announced $38,166,873.04 in new U.S. government task orders through strategic partner Obera LLC, extending performance visibility into 2032, significantly enhancing the company's profitability and market competitiveness for the next six years.
- Enterprise Intelligence Optimization: Clarivate reported fourth quarter revenue of $617 million for fiscal 2025, down from last year, but net income improved sharply to $3.1 million, indicating operational tightening and focus under its Value Creation Plan.
- AI Infrastructure Partnership: AMD and Meta Platforms signed a multi-year agreement to deploy up to 6 gigawatts of AMD Instinct GPUs, with shipments expected to begin in the second half of 2026, further solidifying AMD's competitive position in the AI compute sector.
- Infrastructure Growth Outlook: Ten-League International Holdings projected fiscal 2025 revenue between S$75 million and S$76 million, up approximately 28% to 30% year-over-year, driven by strong infrastructure demand related to the development of Singapore's Changi Airport Terminal 5.
See More
Clarivate to Host Q4 2025 Earnings Call on February 24, 2026
- Earnings Call Announcement: Clarivate Plc will host a conference call on February 24, 2026, at 9:00 AM ET to discuss its Q4 2025 earnings results, aiming to provide investors and analysts with insights into the company's financial health and future outlook.
- Access Details: Investors can join the live webcast via a specified link or dial in using the US number 800-715-9871 and the international number +1 646-307-1963, with conference ID 7258454, ensuring broad dissemination and transparency of information.
- Transparency Enhancement: This earnings call not only serves as a platform for Clarivate to showcase its financial performance but also enhances interaction with investors, aiming to boost market confidence in the company's future developments.
- Market Reaction Expectations: While specific financial data has yet to be disclosed, investor interest in Clarivate's performance in a rapidly changing market environment is high, and the call is expected to have a notable impact on the company's stock price.
See More
Clarivate Reports Strong Q4 Results and Optimistic 2026 Guidance
- Financial Performance Exceeds Expectations: Clarivate reported Q4 2025 revenue of $617 million, surpassing analysts' estimates of $604.8 million, indicating strong performance in the research database and brand management sectors, which boosts market confidence.
- Improved Profitability: The company posted adjusted earnings per share (EPS) of $0.20, exceeding the anticipated $0.16, reflecting ongoing improvements in profitability that may attract more investor interest.
- Free Cash Flow Growth: Clarivate reported Q4 2025 free cash flow of $89.2 million, a 50.9% year-over-year increase, despite a 6.9% decline in sales, demonstrating enhanced operational efficiency.
- Optimistic 2026 Guidance: Management projects adjusted EPS for 2026 between $0.70 and $0.80, with the midpoint indicating an 8.7% year-over-year increase, while free cash flow is expected to range from $365 million to $435 million, highlighting the company's growth potential.
See More
Clarivate Shares Surge 31.4% Following Strong Q4 Earnings Report
- Earnings Beat: Clarivate reported non-GAAP earnings of $0.20 per share and sales of $617 million for Q4, surpassing analyst expectations of $0.16 and $604.8 million, indicating strong market performance despite a year-over-year revenue decline of approximately 7%.
- Stable Subscription Revenue: Subscription revenue decreased slightly from $407 million to $405.8 million, yet organic growth showed a 1% increase, reflecting the company's resilience in maintaining its customer base and revenue streams, which boosts market confidence.
- Optimistic Outlook: Clarivate is targeting a 10% growth in free cash flow this year, with annual contract value expected to grow between 2% and 3%, and recurring organic revenue projected to rise by 1% to 2%, providing investors with confidence that contributed to the stock surge.
- Strategic Restructuring: The company is in active discussions to sell its life sciences and healthcare business to reduce debt and improve its balance sheet, while planning to expand in academia and government and intellectual property sectors, which could lay a foundation for future growth.
See More
Clarivate Exceeds Q4 Sales and Earnings Expectations
- Earnings Beat: Clarivate reported non-GAAP earnings of $0.20 per share and sales of $617 million in Q4, surpassing analyst expectations of $0.16 and $604.8 million, indicating strong market performance.
- Optimistic Sales Outlook: Although revenue declined approximately 7% year-over-year, the drop was less severe than anticipated, with subscription revenue slightly down to $405.8 million but showing a 1% organic growth, reflecting stability in core operations.
- Cash Flow and Contract Value Targets: The company is targeting a 10% growth in free cash flow this year, forecasting a 2% to 3% increase in annual contract value, while organic revenue is projected to rise between 1% and 2%, which will enhance its financial health.
- Strategic Business Sale: Clarivate is in active discussions to sell its life sciences and healthcare business, intending to use the proceeds to reduce debt, improve its balance sheet, and expand in academia and government as well as intellectual property sectors, demonstrating a strategic focus on future growth.
See More
Clarivate Reports Q4 2025 Earnings and Strategic Outlook
- Strong Financial Performance: Clarivate achieved $2.455 billion in revenue for FY 2025, with Q4 revenue at $617 million and a net income of $3 million, demonstrating robust financial growth, particularly with free cash flow reaching $365 million, indicating ongoing improvements in cash management and profitability.
- Strategic Restructuring Plan: The company announced plans to sell its Life Sciences & Health business, which is expected to accelerate shareholder value creation, with management emphasizing that this move will allow for greater focus on operational execution in the Academia & Government and Intellectual Property segments, thereby enhancing market competitiveness.
- AI-Driven Growth: Clarivate's AI products in Life Sciences & Health have attracted 11,000 global active users, with management noting that 97% of revenue comes from proprietary assets, showcasing the company's strong advantage in AI technology application, which helps to enhance customer retention and market share.
- Optimistic Future Outlook: Management anticipates a 10% growth in free cash flow for 2026 and plans to achieve 2% to 3% organic contract value growth, reflecting confidence in future growth while also indicating ongoing investments in innovation and product development.
See More
Defense Contracts Enhance Visibility for NAPC Defense
- Defense Contract Update: NAPC Defense announced $38,166,873.04 in new U.S. government task orders through strategic partner Obera LLC, extending performance visibility into 2032, significantly enhancing the company's profitability and market competitiveness for the next six years.
- Enterprise Intelligence Optimization: Clarivate reported fourth quarter revenue of $617 million for fiscal 2025, down from last year, but net income improved sharply to $3.1 million, indicating operational tightening and focus under its Value Creation Plan.
- AI Infrastructure Partnership: AMD and Meta Platforms signed a multi-year agreement to deploy up to 6 gigawatts of AMD Instinct GPUs, with shipments expected to begin in the second half of 2026, further solidifying AMD's competitive position in the AI compute sector.
- Infrastructure Growth Outlook: Ten-League International Holdings projected fiscal 2025 revenue between S$75 million and S$76 million, up approximately 28% to 30% year-over-year, driven by strong infrastructure demand related to the development of Singapore's Changi Airport Terminal 5.
See More
Clarivate to Host Q4 2025 Earnings Call on February 24, 2026
- Earnings Call Announcement: Clarivate Plc will host a conference call on February 24, 2026, at 9:00 AM ET to discuss its Q4 2025 earnings results, aiming to provide investors and analysts with insights into the company's financial health and future outlook.
- Access Details: Investors can join the live webcast via a specified link or dial in using the US number 800-715-9871 and the international number +1 646-307-1963, with conference ID 7258454, ensuring broad dissemination and transparency of information.
- Transparency Enhancement: This earnings call not only serves as a platform for Clarivate to showcase its financial performance but also enhances interaction with investors, aiming to boost market confidence in the company's future developments.
- Market Reaction Expectations: While specific financial data has yet to be disclosed, investor interest in Clarivate's performance in a rapidly changing market environment is high, and the call is expected to have a notable impact on the company's stock price.
See More
